ArcovaarcovaResources
Sign inStart for free
Resources/How to score readiness
Resources

How to Score Buying Readiness for Life Science Accounts

Score readiness by grouping the signals on an account by what actually changed, leaning hardest on the ones that point at real budget or real need, and letting each fade as it ages. The point is to tell which fit-qualified accounts are worth a message now.

9 min readUpdated Jul 9, 2026

Key takeaways

  • A readiness score works when each signal is scored for the question it answers: a funding round speaks to budget, while a conference appearance speaks to timing and access.
  • Direct, recent evidence of budget or need should carry the most weight.
  • Only score readiness on accounts that already clear fit, so the score tells you when to reach out, not just which account is loudest.

A readiness score is only as good as its honesty about what each signal answers. A Series B round and a conference badge are both worth knowing about, but they answer different questions, and scoring them as if they answered the same one produces a number you cannot act on. The fix is a small set of weighted, fading signal groups instead of a flat signal count.

  1. Group signals by what changed

    Individual events (funding rounds, hires, trial milestones, conference appearances) roll up into a small number of groups that describe what actually changed inside the account. The groupings that matter most in life science selling answer plain questions: did new money or approved spend arrive, did the work just get more complex, did a new decision-maker land, and did the company's direction shift. The exact labels matter less than the discipline of scoring change, not raw activity.

    See timing outreach with readiness signals for the fuller reasoning behind grouping signals this way, and which buying signals actually matter in biotech and pharma for the underlying event catalog they are built from.

  2. Weight by the question each signal answers

    Not every signal answers the same question, and the score should reflect that. The most direct evidence that money or a mandate now exists comes from events like a funding round, an FDA approval, a phase transition, or a demo request; those should move the score most. Organizational change, like hiring into a relevant function or a role change for a tracked contact, says a need is forming and belongs in the middle. Research and visibility events, like a publication, a patent filing, or a conference appearance, are timing and message signals: they tell you how and when to open the conversation, so weight them as openers rather than as evidence of budget.

    Resist the urge to inflate a signal's weight just because it is easy to detect. A conference exhibit list is simple to pull and produces a lot of matches, but exhibiting speaks to reachability and timing, so score it for that job rather than as a budget event.

  3. Apply decay by recency

    A signal's contribution should fade with age, and different kinds of events fade at meaningfully different rates: a demo request needs a same-day response, while a funding round can stay relevant for months. Let each signal's weight fall away as it ages rather than applying one blanket cutoff to every signal, and match the pace to the event: fast for first-party and visibility signals, slower for budget and strategy changes. See timing outreach with readiness signals for how long each kind of signal tends to stay relevant.

  4. Combine with fit into an action

    With the active signals grouped, weighted, and faded for age, pull them together into one honest read per account:

    • Let the most direct, freshest positive change carry the most weight; a single major event usually says more than a handful of minor ones.
    • Treat several kinds of positive change landing at once as a stronger case than any one alone, since it usually points to a real, organization-wide shift rather than an isolated event.
    • Only let the resulting score drive outreach on accounts that already clear fit; see how to score account fit for that gate.

    The output should be an honest read on each fit-qualified account: reach out now when a direct, fresh signal is active, or monitor when fit is good but nothing has happened recently.

Checklist

  • Individual events rolled up into a small number of groups by what actually changed.
  • Each signal weighted by how directly it speaks to new budget or new operational need.
  • Signal contribution faded by age, at a pace matched to that kind of event.
  • Read leans on the most direct, most recent change and treats several signals landing together as a stronger case.
  • Readiness score only applied to accounts that already clear fit.
Where Arcova fits: Arcova watches the underlying public sources continuously for every fit-qualified account and only surfaces "reach out" when a real, current signal is behind the recommendation. The rest of the time a strong-fit account stays on a watch list instead of quietly dropping out of view.
Free preview

See it on your own company

Enter your company domain and Arcova maps your market and target buyers free. No login, about a minute.

Try it free →
Free preview

See it on your own company

Enter your company domain and Arcova maps your market and target buyers free. No login, about a minute.

Try it free →

Frequently asked questions

Can readiness be scored by hand, without a monitoring system?

Yes, on a small account list. The judgment itself, sorting signals by what changed and how direct and recent each one is, works as a manual spreadsheet exercise. What is hard to do by hand is the detection step, watching public sources continuously for new signals across a large account list, which is the part most teams eventually automate once the list outgrows what someone can check weekly.

Why weight signals instead of just counting how many an account has?

A count treats a publication and a funding round as answers to the same question, which produces a score that does not correspond to anything real. An account with one fresh funding round is a stronger case for outreach now than an account with five publications and nothing else, even though the second account has more raw signals; the publications are telling you how to open the conversation, not that budget has arrived. Weighting by how directly a signal implies new budget or new operational need is what makes the score mean something.

Do several signals of the same kind add up to a strong readiness score?

Sometimes, but not by simple addition. Different kinds of change landing at once is meaningful because it usually means a real, organization-wide shift rather than one isolated event, and it should raise confidence more than any single change does alone. Several signals of the same kind (three publications, say) answer the same question three times: they sharpen how you would open the conversation, but they are not added evidence of budget, so they do not make a stronger case for reaching out now.

How does readiness scoring relate to fit scoring?

They are separate layers applied in order. Fit answers whether an account is worth scoring for readiness at all; readiness answers when, inside that fit-qualified list, to actually act. Running readiness scoring across accounts that have not been fit-checked wastes effort surfacing "hot" accounts that were never going to be a good customer. See how to score account fit for the first layer.

Related reading

Guides

Timing outreach with readiness

When to reach out to a life science account, not just who to target: the readiness dimensions behind a buying signal, how quickly they should be acted on, and why they decay at different rates.

Guides

Biotech and pharma buying signals

A working framework for life science buying signals: which events point to new budget or new work to outsource (funding, clinical and regulatory milestones, hiring, expansion), and which fill in the picture around them.

How-to

How to score account fit

A step-by-step method for scoring company and buyer fit in life science sales: define the ICP layers, pick criteria you can actually check, score and band accounts, and act on each band.

See it on your own market

Score the accounts you already have against your ICP.

Bring in the data you already work with, from your CRM or the providers you already use, and Arcova scores it against your ICP, watches for the life science signals that matter, and tells you who is ready for outreach and why.

Start for free
HomeResourcesArcova SignalsCompareHelp centerPrivacyTermsContact
© 2026 Arcova. All rights reserved.